Physician

Kevin Halenda

According to 2025 Medicare claims, Kevin Halenda (NPI: 1053768374) practices ophthalmology in the Morgantown, WV market, with the plurality of this provider's patient population coming from Monongalia, WV. This provider's primary affiliated billing organization is WEST VIRGINIA UNIVERSITY MEDICAL CORPORATION (NPI: 1275504508; TIN: 550492006) and primary practice location at 26506-1200. Halenda is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Halenda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 332 traditional Medicare patients, billed 1,535 HCPCS/CPT codes, and received $114,907 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,560 prescription claims across 420 beneficiaries totaling $151,105 in drug costs, led by Rhopressa (Netarsudil Mesylate). Open Payments data shows 7 records totaling $483. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,608 to $114,907. Similarly, Part D prescription costs have risen steadily, from $768 to $151,105. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$57K$115K2020 Medicare payment: $3,608 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $22,501 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $76,099 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $110,053 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $114,907 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20203133$3,608
2021144380$22,501
2022217965$76,099
20233561,611$110,053
20243321,535$114,907

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$156K$311K2016 Drug cost: $768 (USD; Tot_Drug_Cst)2017 Drug cost: $9,966 (USD; Tot_Drug_Cst)2018 Drug cost: $9,241 (USD; Tot_Drug_Cst)2019 Drug cost: $6,987 (USD; Tot_Drug_Cst)2020 Drug cost: $111,163 (USD; Tot_Drug_Cst)2021 Drug cost: $311,466 (USD; Tot_Drug_Cst)2022 Drug cost: $53,222 (USD; Tot_Drug_Cst)2023 Drug cost: $87,091 (USD; Tot_Drug_Cst)2024 Drug cost: $151,105 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161530$768
20173395$9,966
20183690$9,241
201957128$6,987
2020430977$111,163
20216602,468$311,466
2022238832$53,222
20232861,527$87,091
20244202,560$151,105

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more222390$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more116150$45
92083Exam of visual field with extended testing210246$17
92133Imaging of optic nerve204214$14
92020Exam of the internal drainage system of eye9599$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RhopressaNetarsudil Mesylate1203,687$43,516
LumiganBimatoprost732,687$24,965
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat46829,218$7,753
Prednisolone AcetatePrednisolone Acetate2194,685$7,184
BrinzolamideBrinzolamide281,347$6,254

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$483Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kevin Halenda?

Tedicare shows public-source Medicare data for Kevin Halenda (NPI 1053768374), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Halenda have ACO affiliation data?

Kevin Halenda is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Kevin Halenda?

Kevin Halenda is linked to WEST VIRGINIA UNIVERSITY MEDICAL CORPORATION (billing NPI 1275504508) in the available physician profile data.

Does Kevin Halenda have Open Payments data?

Kevin Halenda has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.